Antibiotherapy at birth in very low birth weight infants before and after the use of interleukin 6 as an infectious biomarker in a tertiary level unit

• Prif Awduron: Sonia Lareu-Vidal (Awdur), Gonzalo Solís-Sánchez (Awdur), María Caunedo-Jiménez (Awdur), Silvia Martín-Ramos (Awdur), Marta Costa-Romero (Awdur), Belén Fernández Colomer (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Permanyer, 2021-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Neonatal sepsis is a condition with high mortality and morbidity that contributes to high rates of antibiotic therapy at birth. In addition, very low birth weight newborns (VLBWN) are particularly vulnerable. Interleukin 6 (IL-6) seems to be an early and effective marker that could help...